Dexin Kong Selected Research

Neoplasm Metastasis (Metastasis)

1/2023	Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.
12/2021	Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway.
10/2021	Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway.
12/2019	Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
1/2019	In Vitro and In Vivo Antimetastatic Effects of ZSTK474 on Prostate Cancer DU145 Cells.
11/2018	Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.
8/2018	Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways.
8/2016	Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.
6/2013	In vitro antimetastatic effect of phosphatidylinositol 3-kinase inhibitor ZSTK474 on prostate cancer PC3 cells.
1/2011	Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dexin Kong Research Topics

Disease

49	Neoplasms (Cancer) 01/2024 - 10/2007
10	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2011
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 04/2004
9	Leukemia 11/2022 - 01/2008
7	Carcinogenesis 10/2023 - 06/2010
5	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 07/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
5	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 06/2013
5	Inflammation (Inflammations) 01/2021 - 10/2007
3	Head and Neck Neoplasms (Head and Neck Cancer) 12/2023 - 05/2021
3	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2016
3	Infections 01/2018 - 12/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 12/2015
2	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 11/2023
2	Hypoxia (Hypoxemia) 09/2023 - 01/2019
2	Human Influenza (Influenza) 08/2023 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2022
2	Heart Failure 10/2021 - 01/2020
2	Tetraploidy 01/2020 - 03/2017
2	Hypersensitivity (Allergy) 06/2019 - 12/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2018 - 06/2017
2	Body Weight (Weight, Body) 01/2018 - 01/2017
2	Asthma (Bronchial Asthma) 08/2017 - 01/2009
1	Iron Deficiencies 05/2024
1	Squamous Cell Carcinoma of Head and Neck 12/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2023
1	Multiple Myeloma 08/2023
1	Influenza in Birds (Avian Flu) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 05/2023

Drug/Important Bio-Agent (IBA)

9	ZSTK474IBA 01/2022 - 10/2007
8	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 09/2008
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2016
5	stellettin BIBA 01/2023 - 07/2014
5	Protein Isoforms (Isoforms)IBA 05/2021 - 10/2007
5	SesquiterpenesIBA 12/2017 - 04/2004
4	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 12/2019
4	idelalisibIBA 09/2022 - 12/2016
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2024 - 01/2017
3	Mitogen-Activated Protein KinasesIBA 12/2023 - 01/2018
3	TriterpenesIBA 01/2021 - 07/2014
3	Immunoglobulin E (IgE)IBA 06/2019 - 08/2017
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 12/2015
3	smenospongineIBA 01/2011 - 04/2004
2	trametinibIBA 12/2023 - 01/2022
2	AlpelisibIBA 12/2023 - 10/2023
2	Proteasome InhibitorsIBA 08/2023 - 01/2021
2	VaccinesIBA 08/2023 - 01/2022
2	hirsuteineIBA 05/2023 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2021
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023 - 09/2008
2	Hormones (Hormone)IBA 01/2023 - 06/2013
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2019
2	Gefitinib (Iressa)FDA Link 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 06/2019
2	NVP-BKM120IBA 11/2021 - 01/2021
2	Digoxin (Digitek)FDA LinkGeneric 10/2021 - 01/2020
2	Insulin (Novolin)FDA Link 05/2021 - 01/2018
2	matrigelIBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2018
2	luteolin-7-glucosideIBA 01/2020 - 03/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2018
2	Chlorogenic AcidIBA 01/2020 - 03/2017
2	IntegrinsIBA 12/2019 - 08/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2009
2	Peptides (Polypeptides)IBA 01/2018 - 01/2018
2	O-diacetylbritannilactone OIBA 12/2017 - 08/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 06/2010
2	TOR Serine-Threonine KinasesIBA 01/2017 - 01/2016
2	Class I Phosphatidylinositol 3-KinasesIBA 01/2017 - 04/2016
2	bcr-abl Fusion ProteinsIBA 12/2016 - 01/2016
2	aaptamineIBA 01/2011 - 03/2006
2	AlkaloidsIBA 03/2006 - 07/2004
1	Basic Helix-Loop-Helix Transcription FactorsIBA 05/2024
1	SaltsIBA 05/2024
1	Amyloid (Amyloid Fibrils)IBA 12/2023
1	ErbB Receptors (EGF Receptor)IBA 12/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2023
1	ButyrylcholinesteraseIBA 11/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2023
1	Hypochlorous Acid (Hypochlorite)IBA 11/2023
1	sapanisertibIBA 09/2023
1	CollagenIBA 09/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2023
1	indium-bleomycinIBA 09/2023
1	ubenimexIBA 08/2023
1	ixazomibIBA 08/2023
1	Hemagglutinins (Hemagglutinin)IBA 08/2023
1	Subunit VaccinesIBA 08/2023
1	Inactivated VaccinesIBA 08/2023
1	Indole AlkaloidsIBA 05/2023
1	Sincalide FDA Link 01/2023

Therapy/Procedure

28	Therapeutics 01/2024 - 09/2008
4	Drug Therapy (Chemotherapy) 08/2023 - 01/2010
2	Oral Administration 01/2019 - 11/2018
1	Photochemotherapy (Photodynamic Therapy) 12/2023